Literature DB >> 12798474

Clinical manifestations and abnormal laboratory findings in pregnant women with primary cytomegalovirus infection.

Giovanni Nigro1, Maurizio M Anceschi, Ermelando V Cosmi.   

Abstract

OBJECTIVE: To compare the clinical manifestations and laboratory abnormalities associated with primary cytomegalovirus (CMV) infection in pregnancy with recurrent and non-active CMV infection (controls).
DESIGN: A prospective cohort study.
SETTING: Rome, Latium and other Italian regions. POPULATION: Three hundred and sixteen pregnant women with CMV infection: 102 had primary infection, 105 had recurrent infection and 109 with non-active infection were followed up as controls.
METHODS: CMV diagnosis was based on serological examinations (CMV IgG, IgM and IgG avidity) and detection of CMV DNA by polymerase chain reaction in maternal serum, urine and cervical samples. The clinical history and laboratory evaluations were carried out at enrollment and at each subsequent visit, every one to three months. MAIN OUTCOME AND MEASURES: Identification of clinical and laboratory indicators of primary CMV infection in pregnancy.
RESULTS: Compared with women with recurrent or non-active infection, women with primary infection had a statistically significant higher prevalence of fever, asthenia, myalgia and flu-like syndrome (P < 0.001). In particular, relevant symptomatology was observed in 32 women (31.4%), of whom 25 had flu-like syndrome and 7 persistent fever as a single manifestation. Moreover, women with primary infection showed a significantly increased rate of lymphocytes >or=40% (39.2% vs 5.7% or 3.7%, respectively, P < 0.001) and elevated aspartate aminotransferase and/or alanine aminotransferase levels (35.3% vs 3.9% or 0.9%, respectively, P < 0.001): lymphocytosis and/or increased aminotransferases occurred in 53 patients (52%). In total, clinical manifestations and/or laboratory abnormalities occurred in 61 women with primary infection (59.8%) compared with 20 with recurrent infection (19%) and 13 controls (11.9%) (P < 0.001).
CONCLUSION: Clinical manifestations (i.e. flu-like syndrome, fever) and abnormal laboratory findings (i.e. lymphocytes >or=40%, elevated aminotransferases) may suggest the presence of primary CMV infection and should prompt subsequent virological investigations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12798474

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  7 in total

1.  Seroprevalence and Seroconversion Rates of Cytomegalovirus pp65 Antigen and Cord Blood Screening of Pregnant Women in Malatya, Turkey.

Authors:  Keziban Dogan; Ayse Kafkasli; Cihan Kaya; Huseyin Cengiz
Journal:  Eurasian J Med       Date:  2013-06

2.  Prevention of maternal cytomegalovirus infection: current status and future prospects.

Authors:  Jessica L Nyholm; Mark R Schleiss
Journal:  Int J Womens Health       Date:  2010-08-09

Review 3.  Congenital cytomegalovirus infection: Clinical presentation, epidemiology, diagnosis and prevention.

Authors:  Wendy J van Zuylen; Stuart T Hamilton; Zin Naing; Beverly Hall; Antonia Shand; William D Rawlinson
Journal:  Obstet Med       Date:  2014-09-25

4.  Washing our hands of the congenital cytomegalovirus disease epidemic.

Authors:  Michael J Cannon; Katherine Finn Davis
Journal:  BMC Public Health       Date:  2005-06-20       Impact factor: 3.295

Review 5.  Vaccines for Perinatal and Congenital Infections-How Close Are We?

Authors:  Tulika Singh; Claire E Otero; Katherine Li; Sarah M Valencia; Ashley N Nelson; Sallie R Permar
Journal:  Front Pediatr       Date:  2020-12-15       Impact factor: 3.418

6.  Clinical and ultrasound features associated with congenital cytomegalovirus infection as potential predictors for targeted newborn screening in high-risk pregnancies.

Authors:  Hitomi Imafuku; Hideto Yamada; Akiko Uchida; Masashi Deguchi; Tokuro Shirakawa; Yuki Sasagawa; Yutoku Shi; Kazumichi Fujioka; Ichiro Morioka; Kenji Tanimura
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

Review 7.  Cytomegalovirus in pregnancy: to screen or not to screen.

Authors:  Susan P Walker; Ricardo Palma-Dias; Erica M Wood; Paul Shekleton; Michelle L Giles
Journal:  BMC Pregnancy Childbirth       Date:  2013-04-18       Impact factor: 3.007

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.